Trial · NCT00654381
Adverse events512
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 512
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Placebo (1st Stage) | 10 | 80 | |
| other | Nasopharyngitis | Infections and infestations | Linagliptin 5mg (2nd-Extension Stage After Placebo) | 10 | 36 | |
| other | Nasopharyngitis | Infections and infestations | Linagliptin 10mg (2nd-Extension Stage After Placebo) | 8 | 38 | |
| other | Nasopharyngitis | Infections and infestations | Linagliptin 5mg (1st-2nd-Extension Stage) | 60 | 159 | |
| other | Nasopharyngitis | Infections and infestations | Linagliptin 10mg (1st-2nd-Extension Stage) | 57 | 160 | |
| other | Nasopharyngitis | Infections and infestations | Voglibose (1st-2nd Stage) | 36 | 162 | |
| other | Nasopharyngitis | Infections and infestations | Linagliptin 5mg (Extension Stage After Voglibose) | 14 | 71 | |
| other | Nasopharyngitis | Infections and infestations | Linagliptin 10mg (Extension Stage After Voglibose) | 16 | 76 | |
| other | Rhinitis | Infections and infestations | Placebo (1st Stage) | 0 | 80 | |
| other | Rhinitis | Infections and infestations | Linagliptin 5mg (2nd-Extension Stage After Placebo) | 2 | 36 | |
| other | Rhinitis | Infections and infestations | Linagliptin 10mg (2nd-Extension Stage After Placebo) | 2 | 38 | |
| other | Rhinitis | Infections and infestations | Linagliptin 5mg (1st-2nd-Extension Stage) | 2 | 159 | |
| other | Rhinitis | Infections and infestations | Linagliptin 10mg (1st-2nd-Extension Stage) | 3 | 160 | |
| other | Rhinitis | Infections and infestations | Voglibose (1st-2nd Stage) | 2 | 162 | |
| other | Rhinitis | Infections and infestations | Linagliptin 5mg (Extension Stage After Voglibose) | 1 | 71 | |
| other | Rhinitis | Infections and infestations | Linagliptin 10mg (Extension Stage After Voglibose) | 0 | 76 | |
| other | Bronchitis | Infections and infestations | Placebo (1st Stage) | 0 | 80 | |
| other | Bronchitis | Infections and infestations | Linagliptin 5mg (2nd-Extension Stage After Placebo) | 1 | 36 | |
| other | Bronchitis | Infections and infestations | Linagliptin 10mg (2nd-Extension Stage After Placebo) | 2 | 38 | |
| other | Bronchitis | Infections and infestations | Linagliptin 5mg (1st-2nd-Extension Stage) | 7 | 159 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00654381/events